These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14240198)

  • 1. [ACTION OF A DUODENAL HEPARINOID ON PLASMA LIPIDS AND SUGARS].
    BERRETA JA; CAMPAGNOLI M; SALITA S; LOFFLER AJ; ZUNDER J; PRESS L; BARBEITOARANDA A; KALINOV A
    Prensa Med Argent; 1964 Nov; 51():1267-71. PubMed ID: 14240198
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF DUODENAL HEPARINOID ON GLUCIDE METABOLISM].
    BARBEITOARANDA A; PRESS L; GIORDANO J; LOPEZGIL AL; CAMPAGNOLI M
    Dia Med; 1963 Sep; 35():1491-3. PubMed ID: 14089621
    [No Abstract]   [Full Text] [Related]  

  • 3. [ACTION OF A SYNTHETIC HEPARINOID ON THE HUMORAL SYNDROME OF ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER ; TADEI
    Rev Atheroscler; 1963; 5():23-31. PubMed ID: 14121729
    [No Abstract]   [Full Text] [Related]  

  • 4. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 5. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE.
    AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G
    G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE EFFECTIVENESS OF ANTIATHEROSCLEROTIC DRUGS].
    SCHOEN H; ZELLER W; DITTERICH S
    Med Klin; 1964 Jun; 59():939-43. PubMed ID: 14234234
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DO HEPARINOIDS HAVE AN EFFECT ON BLOOD SUGAR?A CLINICAL PROBLEM].
    DEGENRING FW
    Med Welt; 1964 Jun; 26():1414-5. PubMed ID: 14227537
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the effect of a heparinoid extracted from the duodenal mucosa on changes of serum lipoids after parenteral fat infusion].
    HAMMERL H; HENK W; HOLLER I; PICHLER O
    Wien Klin Wochenschr; 1963 Jan; 75():64-7. PubMed ID: 13952385
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modifications of the total blood lipids and of various lipid fractions induced by a heparinoid extract of the duodenal mucosa].
    NICROSINI F; PICCINELLI O
    G Clin Med; 1959 Aug; 40():1271-88. PubMed ID: 14427029
    [No Abstract]   [Full Text] [Related]  

  • 11. [The blood, hepatic and aortic lipids in chronic experimental carbon disulfide poisoning in rabbits. Action of duodenal heparinoid extract].
    NICROSINI F; PASOTTI C; DEL FAVERO A; RICOTTI V; MARCHESI E
    Arch Sci Med (Torino); 1963 Feb; 115():109-28. PubMed ID: 13938462
    [No Abstract]   [Full Text] [Related]  

  • 12. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 13. [USE OF A SYNTHETIC HEPARINOID: CB 8061. CONSIDERATIONS ON 50 CASES AFTER 10 MONTHS OF CLINICAL AND BIOLOGICAL TRIALS].
    MANS J; GENES M
    J Med Bord; 1963 Dec; 140():1886-93. PubMed ID: 14099058
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the clearing action of a heparinoid obtained from duodenal mucosa].
    HAMMERL H; PICHLER O
    Clin Ter; 1963 May; 25():250-7. PubMed ID: 13952389
    [No Abstract]   [Full Text] [Related]  

  • 15. [BLOOD SERUM CHOLESTEROL AND TOTAL BLOOD LIPIDS IN 3324 EXAMINED SUBJECTS].
    RETSAGI G; KELLER L
    Orv Hetil; 1964 Nov; 105():2225-9. PubMed ID: 14232613
    [No Abstract]   [Full Text] [Related]  

  • 16. [Duodenal heparinoid action on carbohydrate metabolism vegulation in diabetics].
    Puchulu FE; Suárez Pereda I; Martí ML; Ruiz M
    Prensa Med Argent; 1967 Mar; 54(4):178-80. PubMed ID: 4175021
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and hematochemical observations on the geriatric and gerioprophylactic applications of a heparinoid agent associated with hormovitaminic factors and iodine].
    BENEDETTI G; MAZZA F; FERRETTI GF
    Minerva Med; 1961 Sep; 52():3347-51. PubMed ID: 13867125
    [No Abstract]   [Full Text] [Related]  

  • 18. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

  • 19. QUANTITATIVE ASPECTS OF LABILE DIABETES.
    MOLNAR GD; GASTINEAU CF; ROSEVEAR JW; MOXNESS KE
    Diabetes; 1965 May; 14():279-88. PubMed ID: 14280369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.